NCT02152176

Brief Summary

Intense acute pain is a common reason for Emergency admittance and its management is one of the major public health goals. In the recommendations formalized experts, it is recommended to use a protocol titration with morphine bolus of 2 mg (for patients less than 60 kg) or 3 mg (for patients over 60 kg) repeated every 5 minutes with a target of the Visual Analog Scale less than or equal to 30. Despite these specific recommendations and a broad awareness of the teams, management of pain remains to be improved, the major difficulty of morphine titration at the emergency department being the availability of paramedical personnel to perform revaluations and reinjection. Thus, effective analgesia would be obtained in 50% of cases to 30 minutes. The investigators want to study the self-controlled morphine titration by the patient by a mechanical device for single use (efficacy/safety).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Jul 2014

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 22, 2014

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 2, 2014

Completed
29 days until next milestone

Study Start

First participant enrolled

July 1, 2014

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2016

Completed
Last Updated

June 30, 2016

Status Verified

June 1, 2016

Enrollment Period

1.6 years

First QC Date

May 22, 2014

Last Update Submit

June 29, 2016

Conditions

Keywords

painanalgesiamorphinePCANurse

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Scale <30

    Evaluate the effectiveness of the analgesia of morphine titration self-controlled by the patient using a PCA device for single use ("PCA" group) opposing to an opioid titration carried out by the nurse (group 'Control')

    30min

Secondary Outcomes (2)

  • Evaluate the effectiveness in the group Patient Controlled Analgesy

    4h

  • Satisfaction

    4h

Other Outcomes (1)

  • Assess the safety in the group Patient Controlled Analgesy

    4h

Study Arms (2)

Patient Controlled Analgesy group

EXPERIMENTAL

Titration of morphine by Patient Controlled Analgesy. The opioid titration will be performed by the patient using PCA (Vygon Freedom 5) according to the principle of self with a refractory period of 5 minutes.

Device: Titration of morphine by Patient Controlled Analgesy

Control group

NO INTERVENTION

titration will be perform in the usual manner in accordance with the recommendations : a nurse will assess pain using a visual analog scale in the control group to assess the need for a new bolus of morphine

Interventions

PCA is never used for titration but only for relay of titration. Self-controlled analgesia by PCA is our intervention.

Patient Controlled Analgesy group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Admission to an emergency department
  • Acute pain (Visual Analog Scale \> 60)
  • Able to assess pain using the numerical scale
  • Prescription of morphine titration

You may not qualify if:

  • Physical or mental disorders limiting the understanding and / or use of a PCA
  • History of allergy to morphine / hypersensitivity to any component
  • Long-term treatment morphine
  • History of Substance Abuse
  • Severe respiratory insufficiency
  • Severe hepatic impairment
  • Head trauma
  • Intracranial hypertension
  • Uncontrolled epilepsy
  • Pregnant or lactating
  • Patient jailed
  • Incapacitated adult under guardianship
  • Incapable of giving informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

SCHOTTE Thibault

Angers, 49933, France

Location

CHOUKROUN Jacques

Le Mans, France

Location

MeSH Terms

Conditions

Acute PainPainAgnosia

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Study Officials

  • ROY Pierre-Marie, MD-PhD

    UH Angers

    STUDY CHAIR
  • SCHOTTE Thibault, Physician

    UH Angers

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 22, 2014

First Posted

June 2, 2014

Study Start

July 1, 2014

Primary Completion

February 1, 2016

Study Completion

February 1, 2016

Last Updated

June 30, 2016

Record last verified: 2016-06

Locations